Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): A randomised, open-label trial

The Lancet

Volumn 381, Issue 9865, 2013, Pages 461-467

  Byrne, Robert A ^a   Neumann, Franz Josef ^c   Mehilli, Julinda ^d   Pinieck, Susanne ^a   Wolff, Britta ^a   Tiroch, Klaus ^e   Schulz, Stefanie ^a   Fusaro, Massimiliano ^a   Ott, Ilka ^a   Ibrahim, Tareq ^b   Hausleiter, Jörg ^d   Valina, Christian ^c   Pache, Jürgen ^f   Laugwitz, Karl Ludwig ^b   Massberg, Steffen ^d   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e HELIOS KLINIKUM WUPPERTAL   (Germany)

^f Abteilung Hämatologie und Onkologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; SEQUENT PLEASE; TAXUS LIBERTE; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BALLOON; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG FATALITY; FEMALE; FOLLOW UP; GERMANY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PACLITAXEL ELUTING BALLOON; PACLITAXEL ELUTING STENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; THROMBOSIS;

EID: 84873706439     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61964-3     Document Type: Article

References (32)

1. PW Serruys, MJ Kutryk, AT Ong Coronary-artery stents N Engl J Med 354 2006 483 495
2. OC Marroquin, F Selzer, SR Mulukutla et al. A comparison of bare-metal and drug-eluting stents for off-label indications N Engl J Med 358 2008 342 352
3. RA Byrne, N Sarafoff, A Kastrati, A Schomig Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment Drug Saf 32 2009 749 770
4. GD Dangas, BE Claessen, A Caixeta, EA Sanidas, GS Mintz, R Mehran In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 2010 1897 1907
5. A Kastrati, R Byrne New roads, new ruts: lessons from drug-eluting stent restenosis JACC Cardiovasc Interv 4 2011 165 167
6. A Latib, M Mussardo, A Ielasi et al. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis JACC Cardiovasc Interv 4 2011 155 164
7. J Mehilli, RA Byrne, K Tiroch et al. Randomized trial of paclitaxel-versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J Am Coll Cardiol 55 2010 2710 2716
8. F Alfonso, J Garcia, MJ Perez-Vizcayno et al. New stent implantation for recurrences after stenting for in-stent restenosis: implications of a third metal layer in human coronary arteries J Am Coll Cardiol 54 2009 1036 1038
9. WA Gray, JF Granada Drug-coated balloons for the prevention of vascular restenosis Circulation 121 2010 2672 2680
10. R Mehran, G Dangas, AS Abizaid et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878
11. RA Byrne, A Kastrati, S Kufner et al. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial Eur Heart J 30 2009 2441 2449
12. DE Cutlip, S Windecker, R Mehran et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
13. M Unverdorben, C Vallbracht, B Cremers et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
14. A Kastrati, J Mehilli, N von Beckerath et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2005 165 171
15. G Piaggio, DR Elbourne, DG Altman, SJ Pocock, SJ Evans Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement JAMA 295 2006 1152 1160
16. SL Zeger, KY Liang, PS Albert Models for longitudinal data: a generalized estimating equation approach Biometrics 44 1988 1049 1060
17. F Alfonso, MJ Perez-Vizcayno, R Hernandez et al. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial J Am Coll Cardiol 47 2006 2152 2160
18. DR Holmes Jr, P Teirstein, L Satler et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial JAMA 295 2006 1264 1273
19. GW Stone, SG Ellis, CD O'Shaughnessy et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial JAMA 295 2006 1253 1263
20. B Scheller, C Hehrlein, W Bocksch et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
21. RA Byrne, M Joner, T Tada, A Kastrati Restenosis in bare metal and drug-eluting stents: distinct mechanistic insights from histopathology and optical intravascular imaging Minerva Cardioangiol 60 2012 473 489
22. H Takagi, T Umemoto An updated meta-analysis of randomized controlled trials of everolimus- versus paclitaxel-eluting stents Int J Cardiol 151 2011 354 355
23. DH Steinberg, MA Gaglia Jr, TL Pinto Slottow et al. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents Am J Cardiol 103 2009 491 495
24. J Wohrle, M Zadura, S Mobius-Winkler et al. SeQuent please world wide registry: clinical results of SeQuent Please Paclitaxel-Coated Balloon Angioplasty in a Large-Scale, Prospective Registry Study J Am Coll Cardiol 60 2012 1733 1738
25. S Habara, K Mitsudo, K Kadota et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis JACC Cardiovasc Interv 4 2011 149 154
26. H Rittger, J Brachmann, AM Sinha et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 2012 1377 1382
27. RE Kuntz, RD Safian, MJ Levine, GJ Reis, DJ Diver, DS Baim Novel approach to the analysis of restenosis after the use of three new coronary devices J Am Coll Cardiol 19 1992 1493 1499
28. L Mauri, EJ Orav, AJ O'Malley et al. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents Circulation 111 2005 321 327
29. SJ Pocock, AJ Lansky, R Mehran et al. Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials J Am Coll Cardiol 51 2008 23 32
30. T Uchida, J Popma, GW Stone et al. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions JACC Cardiovasc Interv 3 2010 403 411
31. M Joner, RA Byrne, JM Lapointe et al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis Thromb Haemost 105 2011 864 872
32. S Cassese, A Kastrati Not all drug-eluting balloons are equally good for patients, not all patients are equally suitable for drug-eluting balloons EuroIntervention 8 2012 417 421